版本:
中国

BRIEF-Ocular Therapeutix(Tm) starts enrollment in phase 3 clinical trial with OTX-TP

Oct 4 Ocular Therapeutix(Tm)

* Begins Enrollment In First Phase 3 Clinical Trial With Otx Tp (sustained release travoprost) for the treatment of glaucoma and ocular hypertension

* Says plan to commence second phase 3 clinical trial in first half of 2017

* Says expect topline results from first phase 3 clinical trial to be available in first half of 2018 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐